Global Restless Legs Syndrome Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Restless Legs Syndrome Market Size 2017-2028

2.1.2 Restless Legs Syndrome Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Restless Legs Syndrome Segment by Type

2.2.1 Pharmacological Therapy

2.2.2 Non-Pharmacological Therapy

2.3 Restless Legs Syndrome Market Size by Type

2.3.1 Restless Legs Syndrome Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Restless Legs Syndrome Market Size Market Share by Type (2017-2022)

2.4 Restless Legs Syndrome Segment by End User

2.4.1 Below 35 Years Old

2.4.2 From 35 to 50 Years Old

2.4.3 Above 50 Years Old

2.5 Restless Legs Syndrome Market Size by End User

2.5.1 Restless Legs Syndrome Market Size CAGR by End User (2017 VS 2022 VS 2028)

2.5.2 Global Restless Legs Syndrome Market Size Market Share by End User (2017-2022)

3 Restless Legs Syndrome Market Size by Player

3.1 Restless Legs Syndrome Market Size Market Share by Players

3.1.1 Global Restless Legs Syndrome Revenue by Players (2020-2022)

3.1.2 Global Restless Legs Syndrome Revenue Market Share by Players (2020-2022)

3.2 Global Restless Legs Syndrome Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Restless Legs Syndrome by Regions

4.1 Restless Legs Syndrome Market Size by Regions (2017-2022)

4.2 Americas Restless Legs Syndrome Market Size Growth (2017-2022)

4.3 APAC Restless Legs Syndrome Market Size Growth (2017-2022)

4.4 Europe Restless Legs Syndrome Market Size Growth (2017-2022)

4.5 Middle East & Africa Restless Legs Syndrome Market Size Growth (2017-2022)

5 Americas

5.1 Americas Restless Legs Syndrome Market Size by Country (2017-2022)

5.2 Americas Restless Legs Syndrome Market Size by Type (2017-2022)

5.3 Americas Restless Legs Syndrome Market Size by End User (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Restless Legs Syndrome Market Size by Region (2017-2022)

6.2 APAC Restless Legs Syndrome Market Size by Type (2017-2022)

6.3 APAC Restless Legs Syndrome Market Size by End User (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Restless Legs Syndrome by Country (2017-2022)

7.2 Europe Restless Legs Syndrome Market Size by Type (2017-2022)

7.3 Europe Restless Legs Syndrome Market Size by End User (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Restless Legs Syndrome by Region (2017-2022)

8.2 Middle East & Africa Restless Legs Syndrome Market Size by Type (2017-2022)

8.3 Middle East & Africa Restless Legs Syndrome Market Size by End User (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Restless Legs Syndrome Market Forecast

10.1 Global Restless Legs Syndrome Forecast by Regions (2023-2028)

10.1.1 Global Restless Legs Syndrome Forecast by Regions (2023-2028)

10.1.2 Americas Restless Legs Syndrome Forecast

10.1.3 APAC Restless Legs Syndrome Forecast

10.1.4 Europe Restless Legs Syndrome Forecast

10.1.5 Middle East & Africa Restless Legs Syndrome Forecast

10.2 Americas Restless Legs Syndrome Forecast by Country (2023-2028)

10.2.1 United States Restless Legs Syndrome Market Forecast

10.2.2 Canada Restless Legs Syndrome Market Forecast

10.2.3 Mexico Restless Legs Syndrome Market Forecast

10.2.4 Brazil Restless Legs Syndrome Market Forecast

10.3 APAC Restless Legs Syndrome Forecast by Region (2023-2028)

10.3.1 China Restless Legs Syndrome Market Forecast

10.3.2 Japan Restless Legs Syndrome Market Forecast

10.3.3 Korea Restless Legs Syndrome Market Forecast

10.3.4 Southeast Asia Restless Legs Syndrome Market Forecast

10.3.5 India Restless Legs Syndrome Market Forecast

10.3.6 Australia Restless Legs Syndrome Market Forecast

10.4 Europe Restless Legs Syndrome Forecast by Country (2023-2028)

10.4.1 Germany Restless Legs Syndrome Market Forecast

10.4.2 France Restless Legs Syndrome Market Forecast

10.4.3 UK Restless Legs Syndrome Market Forecast

10.4.4 Italy Restless Legs Syndrome Market Forecast

10.4.5 Russia Restless Legs Syndrome Market Forecast

10.5 Middle East & Africa Restless Legs Syndrome Forecast by Region (2023-2028)

10.5.1 Egypt Restless Legs Syndrome Market Forecast

10.5.2 South Africa Restless Legs Syndrome Market Forecast

10.5.3 Israel Restless Legs Syndrome Market Forecast

10.5.4 Turkey Restless Legs Syndrome Market Forecast

10.5.5 GCC Countries Restless Legs Syndrome Market Forecast

10.6 Global Restless Legs Syndrome Forecast by Type (2023-2028)

10.7 Global Restless Legs Syndrome Forecast by End User (2023-2028)

11 Key Players Analysis

11.1 Boehringer Ingelheim GmbH

11.1.1 Boehringer Ingelheim GmbH Company Information

11.1.2 Boehringer Ingelheim GmbH Restless Legs Syndrome Product Offered

11.1.3 Boehringer Ingelheim GmbH Restless Legs Syndrome Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Boehringer Ingelheim GmbH Main Business Overview

11.1.5 Boehringer Ingelheim GmbH Latest Developments

11.2 UCB SA

11.2.1 UCB SA Company Information

11.2.2 UCB SA Restless Legs Syndrome Product Offered

11.2.3 UCB SA Restless Legs Syndrome Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 UCB SA Main Business Overview

11.2.5 UCB SA Latest Developments

11.3 Astellas

11.3.1 Astellas Company Information

11.3.2 Astellas Restless Legs Syndrome Product Offered

11.3.3 Astellas Restless Legs Syndrome Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Astellas Main Business Overview

11.3.5 Astellas Latest Developments

11.4 Arbor Pharmaceuticals

11.4.1 Arbor Pharmaceuticals Company Information

11.4.2 Arbor Pharmaceuticals Restless Legs Syndrome Product Offered

11.4.3 Arbor Pharmaceuticals Restless Legs Syndrome Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Arbor Pharmaceuticals Main Business Overview

11.4.5 Arbor Pharmaceuticals Latest Developments

11.5 GlaxoSmithKline plc.

11.5.1 GlaxoSmithKline plc. Company Information

11.5.2 GlaxoSmithKline plc. Restless Legs Syndrome Product Offered

11.5.3 GlaxoSmithKline plc. Restless Legs Syndrome Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 GlaxoSmithKline plc. Main Business Overview

11.5.5 GlaxoSmithKline plc. Latest Developments

11.6 Ligand Pharmaceuticals Incorporated

11.6.1 Ligand Pharmaceuticals Incorporated Company Information

11.6.2 Ligand Pharmaceuticals Incorporated Restless Legs Syndrome Product Offered

11.6.3 Ligand Pharmaceuticals Incorporated Restless Legs Syndrome Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Ligand Pharmaceuticals Incorporated Main Business Overview

11.6.5 Ligand Pharmaceuticals Incorporated Latest Developments

11.7 axxonis Pharma AG

11.7.1 axxonis Pharma AG Company Information

11.7.2 axxonis Pharma AG Restless Legs Syndrome Product Offered

11.7.3 axxonis Pharma AG Restless Legs Syndrome Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 axxonis Pharma AG Main Business Overview

11.7.5 axxonis Pharma AG Latest Developments

11.8 Kyowa Hakko Kirin Co.

11.8.1 Kyowa Hakko Kirin Co. Company Information

11.8.2 Kyowa Hakko Kirin Co. Restless Legs Syndrome Product Offered

11.8.3 Kyowa Hakko Kirin Co. Restless Legs Syndrome Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Kyowa Hakko Kirin Co. Main Business Overview

11.8.5 Kyowa Hakko Kirin Co. Latest Developments

11.9 Jazz Pharmaceuticals, Inc.

11.9.1 Jazz Pharmaceuticals, Inc. Company Information

11.9.2 Jazz Pharmaceuticals, Inc. Restless Legs Syndrome Product Offered

11.9.3 Jazz Pharmaceuticals, Inc. Restless Legs Syndrome Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Jazz Pharmaceuticals, Inc. Main Business Overview

11.9.5 Jazz Pharmaceuticals, Inc. Latest Developments

11.10 Omeros Corporation

11.10.1 Omeros Corporation Company Information

11.10.2 Omeros Corporation Restless Legs Syndrome Product Offered

11.10.3 Omeros Corporation Restless Legs Syndrome Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Omeros Corporation Main Business Overview

11.10.5 Omeros Corporation Latest Developments

11.11 Manhattan Pharmaceuticals

11.11.1 Manhattan Pharmaceuticals Company Information

11.11.2 Manhattan Pharmaceuticals Restless Legs Syndrome Product Offered

11.11.3 Manhattan Pharmaceuticals Restless Legs Syndrome Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Manhattan Pharmaceuticals Main Business Overview

11.11.5 Manhattan Pharmaceuticals Latest Developments

12 Research Findings and Conclusion

Table 1. Restless Legs Syndrome Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Pharmacological Therapy

Table 3. Major Players of Non-Pharmacological Therapy

Table 4. Restless Legs Syndrome Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 5. Global Restless Legs Syndrome Market Size by Type (2017-2022) & ($ Millions)

Table 6. Global Restless Legs Syndrome Market Size Market Share by Type (2017-2022)

Table 7. Restless Legs Syndrome Market Size CAGR by End User (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Restless Legs Syndrome Market Size by End User (2017-2022) & ($ Millions)

Table 9. Global Restless Legs Syndrome Market Size Market Share by End User (2017-2022)

Table 10. Global Restless Legs Syndrome Revenue by Players (2020-2022) & ($ Millions)

Table 11. Global Restless Legs Syndrome Revenue Market Share by Player (2020-2022)

Table 12. Restless Legs Syndrome Key Players Head office and Products Offered

Table 13. Restless Legs Syndrome Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 14. New Products and Potential Entrants

Table 15. Mergers & Acquisitions, Expansion

Table 16. Global Restless Legs Syndrome Market Size by Regions 2017-2022 & ($ Millions)

Table 17. Global Restless Legs Syndrome Market Size Market Share by Regions (2017-2022)

Table 18. Americas Restless Legs Syndrome Market Size by Country (2017-2022) & ($ Millions)

Table 19. Americas Restless Legs Syndrome Market Size Market Share by Country (2017-2022)

Table 20. Americas Restless Legs Syndrome Market Size by Type (2017-2022) & ($ Millions)

Table 21. Americas Restless Legs Syndrome Market Size Market Share by Type (2017-2022)

Table 22. Americas Restless Legs Syndrome Market Size by End User (2017-2022) & ($ Millions)

Table 23. Americas Restless Legs Syndrome Market Size Market Share by End User (2017-2022)

Table 24. APAC Restless Legs Syndrome Market Size by Region (2017-2022) & ($ Millions)

Table 25. APAC Restless Legs Syndrome Market Size Market Share by Region (2017-2022)

Table 26. APAC Restless Legs Syndrome Market Size by Type (2017-2022) & ($ Millions)

Table 27. APAC Restless Legs Syndrome Market Size Market Share by Type (2017-2022)

Table 28. APAC Restless Legs Syndrome Market Size by End User (2017-2022) & ($ Millions)

Table 29. APAC Restless Legs Syndrome Market Size Market Share by End User (2017-2022)

Table 30. Europe Restless Legs Syndrome Market Size by Country (2017-2022) & ($ Millions)

Table 31. Europe Restless Legs Syndrome Market Size Market Share by Country (2017-2022)

Table 32. Europe Restless Legs Syndrome Market Size by Type (2017-2022) & ($ Millions)

Table 33. Europe Restless Legs Syndrome Market Size Market Share by Type (2017-2022)

Table 34. Europe Restless Legs Syndrome Market Size by End User (2017-2022) & ($ Millions)

Table 35. Europe Restless Legs Syndrome Market Size Market Share by End User (2017-2022)

Table 36. Middle East & Africa Restless Legs Syndrome Market Size by Region (2017-2022) & ($ Millions)

Table 37. Middle East & Africa Restless Legs Syndrome Market Size Market Share by Region (2017-2022)

Table 38. Middle East & Africa Restless Legs Syndrome Market Size by Type (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Restless Legs Syndrome Market Size Market Share by Type (2017-2022)

Table 40. Middle East & Africa Restless Legs Syndrome Market Size by End User (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Restless Legs Syndrome Market Size Market Share by End User (2017-2022)

Table 42. Key Market Drivers & Growth Opportunities of Restless Legs Syndrome

Table 43. Key Market Challenges & Risks of Restless Legs Syndrome

Table 44. Key Industry Trends of Restless Legs Syndrome

Table 45. Global Restless Legs Syndrome Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 46. Global Restless Legs Syndrome Market Size Market Share Forecast by Regions (2023-2028)

Table 47. Global Restless Legs Syndrome Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 48. Global Restless Legs Syndrome Market Size Market Share Forecast by Type (2023-2028)

Table 49. Global Restless Legs Syndrome Market Size Forecast by End User (2023-2028) & ($ Millions)

Table 50. Global Restless Legs Syndrome Market Size Market Share Forecast by End User (2023-2028)

Table 51. Boehringer Ingelheim GmbH Details, Company Type, Restless Legs Syndrome Area Served and Its Competitors

Table 52. Boehringer Ingelheim GmbH Restless Legs Syndrome Product Offered

Table 53. Boehringer Ingelheim GmbH Restless Legs Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 54. Boehringer Ingelheim GmbH Main Business

Table 55. Boehringer Ingelheim GmbH Latest Developments

Table 56. UCB SA Details, Company Type, Restless Legs Syndrome Area Served and Its Competitors

Table 57. UCB SA Restless Legs Syndrome Product Offered

Table 58. UCB SA Main Business

Table 59. UCB SA Restless Legs Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 60. UCB SA Latest Developments

Table 61. Astellas Details, Company Type, Restless Legs Syndrome Area Served and Its Competitors

Table 62. Astellas Restless Legs Syndrome Product Offered

Table 63. Astellas Main Business

Table 64. Astellas Restless Legs Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 65. Astellas Latest Developments

Table 66. Arbor Pharmaceuticals Details, Company Type, Restless Legs Syndrome Area Served and Its Competitors

Table 67. Arbor Pharmaceuticals Restless Legs Syndrome Product Offered

Table 68. Arbor Pharmaceuticals Main Business

Table 69. Arbor Pharmaceuticals Restless Legs Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 70. Arbor Pharmaceuticals Latest Developments

Table 71. GlaxoSmithKline plc. Details, Company Type, Restless Legs Syndrome Area Served and Its Competitors

Table 72. GlaxoSmithKline plc. Restless Legs Syndrome Product Offered

Table 73. GlaxoSmithKline plc. Main Business

Table 74. GlaxoSmithKline plc. Restless Legs Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 75. GlaxoSmithKline plc. Latest Developments

Table 76. Ligand Pharmaceuticals Incorporated Details, Company Type, Restless Legs Syndrome Area Served and Its Competitors

Table 77. Ligand Pharmaceuticals Incorporated Restless Legs Syndrome Product Offered

Table 78. Ligand Pharmaceuticals Incorporated Main Business

Table 79. Ligand Pharmaceuticals Incorporated Restless Legs Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 80. Ligand Pharmaceuticals Incorporated Latest Developments

Table 81. axxonis Pharma AG Details, Company Type, Restless Legs Syndrome Area Served and Its Competitors

Table 82. axxonis Pharma AG Restless Legs Syndrome Product Offered

Table 83. axxonis Pharma AG Main Business

Table 84. axxonis Pharma AG Restless Legs Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 85. axxonis Pharma AG Latest Developments

Table 86. Kyowa Hakko Kirin Co. Details, Company Type, Restless Legs Syndrome Area Served and Its Competitors

Table 87. Kyowa Hakko Kirin Co. Restless Legs Syndrome Product Offered

Table 88. Kyowa Hakko Kirin Co. Main Business

Table 89. Kyowa Hakko Kirin Co. Restless Legs Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 90. Kyowa Hakko Kirin Co. Latest Developments

Table 91. Jazz Pharmaceuticals, Inc. Details, Company Type, Restless Legs Syndrome Area Served and Its Competitors

Table 92. Jazz Pharmaceuticals, Inc. Restless Legs Syndrome Product Offered

Table 93. Jazz Pharmaceuticals, Inc. Main Business

Table 94. Jazz Pharmaceuticals, Inc. Restless Legs Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 95. Jazz Pharmaceuticals, Inc. Latest Developments

Table 96. Omeros Corporation Details, Company Type, Restless Legs Syndrome Area Served and Its Competitors

Table 97. Omeros Corporation Restless Legs Syndrome Product Offered

Table 98. Omeros Corporation Main Business

Table 99. Omeros Corporation Restless Legs Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 100. Omeros Corporation Latest Developments

Table 101. Manhattan Pharmaceuticals Details, Company Type, Restless Legs Syndrome Area Served and Its Competitors

Table 102. Manhattan Pharmaceuticals Restless Legs Syndrome Product Offered

Table 103. Manhattan Pharmaceuticals Restless Legs Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 104. Manhattan Pharmaceuticals Main Business

Table 105. Manhattan Pharmaceuticals Latest Developments

List of Figures

Figure 1. Restless Legs Syndrome Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Restless Legs Syndrome Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Restless Legs Syndrome Market Size Market Share by Type in 2021

Figure 7. Restless Legs Syndrome in Below 35 Years Old

Figure 8. Global Restless Legs Syndrome Market: Below 35 Years Old (2017-2022) & ($ Millions)

Figure 9. Restless Legs Syndrome in From 35 to 50 Years Old

Figure 10. Global Restless Legs Syndrome Market: From 35 to 50 Years Old (2017-2022) & ($ Millions)

Figure 11. Restless Legs Syndrome in Above 50 Years Old

Figure 12. Global Restless Legs Syndrome Market: Above 50 Years Old (2017-2022) & ($ Millions)

Figure 13. Global Restless Legs Syndrome Market Size Market Share by End User in 2021

Figure 14. Global Restless Legs Syndrome Revenue Market Share by Player in 2021

Figure 15. Global Restless Legs Syndrome Market Size Market Share by Regions (2017-2022)

Figure 16. Americas Restless Legs Syndrome Market Size 2017-2022 ($ Millions)

Figure 17. APAC Restless Legs Syndrome Market Size 2017-2022 ($ Millions)

Figure 18. Europe Restless Legs Syndrome Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa Restless Legs Syndrome Market Size 2017-2022 ($ Millions)

Figure 20. Americas Restless Legs Syndrome Value Market Share by Country in 2021

Figure 21. Americas Restless Legs Syndrome Consumption Market Share by Type in 2021

Figure 22. Americas Restless Legs Syndrome Market Size Market Share by End User in 2021

Figure 23. United States Restless Legs Syndrome Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada Restless Legs Syndrome Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico Restless Legs Syndrome Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil Restless Legs Syndrome Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC Restless Legs Syndrome Market Size Market Share by Region in 2021

Figure 28. APAC Restless Legs Syndrome Market Size Market Share by End User in 2021

Figure 29. China Restless Legs Syndrome Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan Restless Legs Syndrome Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea Restless Legs Syndrome Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia Restless Legs Syndrome Market Size Growth 2017-2022 ($ Millions)

Figure 33. India Restless Legs Syndrome Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia Restless Legs Syndrome Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe Restless Legs Syndrome Market Size Market Share by Country in 2021

Figure 36. Europe Restless Legs Syndrome Market Size Market Share by Type in 2021

Figure 37. Europe Restless Legs Syndrome Market Size Market Share by End User in 2021

Figure 38. Germany Restless Legs Syndrome Market Size Growth 2017-2022 ($ Millions)

Figure 39. France Restless Legs Syndrome Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK Restless Legs Syndrome Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy Restless Legs Syndrome Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia Restless Legs Syndrome Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa Restless Legs Syndrome Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa Restless Legs Syndrome Market Size Market Share by Type in 2021

Figure 45. Middle East & Africa Restless Legs Syndrome Market Size Market Share by End User in 2021

Figure 46. Egypt Restless Legs Syndrome Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa Restless Legs Syndrome Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel Restless Legs Syndrome Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey Restless Legs Syndrome Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country Restless Legs Syndrome Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas Restless Legs Syndrome Market Size 2023-2028 ($ Millions)

Figure 52. APAC Restless Legs Syndrome Market Size 2023-2028 ($ Millions)

Figure 53. Europe Restless Legs Syndrome Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa Restless Legs Syndrome Market Size 2023-2028 ($ Millions)

Figure 55. United States Restless Legs Syndrome Market Size 2023-2028 ($ Millions)

Figure 56. Canada Restless Legs Syndrome Market Size 2023-2028 ($ Millions)

Figure 57. Mexico Restless Legs Syndrome Market Size 2023-2028 ($ Millions)

Figure 58. Brazil Restless Legs Syndrome Market Size 2023-2028 ($ Millions)

Figure 59. China Restless Legs Syndrome Market Size 2023-2028 ($ Millions)

Figure 60. Japan Restless Legs Syndrome Market Size 2023-2028 ($ Millions)

Figure 61. Korea Restless Legs Syndrome Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia Restless Legs Syndrome Market Size 2023-2028 ($ Millions)

Figure 63. India Restless Legs Syndrome Market Size 2023-2028 ($ Millions)

Figure 64. Australia Restless Legs Syndrome Market Size 2023-2028 ($ Millions)

Figure 65. Germany Restless Legs Syndrome Market Size 2023-2028 ($ Millions)

Figure 66. France Restless Legs Syndrome Market Size 2023-2028 ($ Millions)

Figure 67. UK Restless Legs Syndrome Market Size 2023-2028 ($ Millions)

Figure 68. Italy Restless Legs Syndrome Market Size 2023-2028 ($ Millions)

Figure 69. Russia Restless Legs Syndrome Market Size 2023-2028 ($ Millions)

Figure 70. Spain Restless Legs Syndrome Market Size 2023-2028 ($ Millions)

Figure 71. Egypt Restless Legs Syndrome Market Size 2023-2028 ($ Millions)

Figure 72. South Africa Restless Legs Syndrome Market Size 2023-2028 ($ Millions)

Figure 73. Israel Restless Legs Syndrome Market Size 2023-2028 ($ Millions)

Figure 74. Turkey Restless Legs Syndrome Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries Restless Legs Syndrome Market Size 2023-2028 ($ Millions)